相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment
Gita Manzari Tavakoli et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
A Role for Microsomal Glutathione Transferase 1 in Melanin Biosynthesis and Melanoma Progression.
Jie Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2023)
The role of ferroptosis in melanoma
Ronan Talty et al.
PIGMENT CELL & MELANOMA RESEARCH (2022)
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
Melina Arnold et al.
JAMA DERMATOLOGY (2022)
Treatment of Advanced Metastatic Melanoma
Pietro Quaglino et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)
Mitochondrial oxidative phosphorylation in cutaneous melanoma
Prakrit R. Kumar et al.
BRITISH JOURNAL OF CANCER (2021)
Redox Regulation in Cancer Cells during Metastasis
Alpaslan Tasdogan et al.
CANCER DISCOVERY (2021)
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Stefania Pizzimenti et al.
ANTIOXIDANTS (2021)
MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells
Feimei Kuang et al.
CELL CHEMICAL BIOLOGY (2021)
Metabolic heterogeneity confers differences in melanoma metastatic potential
Alpaslan Tasdogan et al.
NATURE (2020)
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Eva Perez-Guijarro et al.
NATURE MEDICINE (2020)
Ferroptosis: a new unexpected chance to treat metastatic melanoma?
Mara Gagliardi et al.
CELL CYCLE (2020)
Lymph protects metastasizing melanoma cells from ferroptosis
Jessalyn M. Ubellacker et al.
NATURE (2020)
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
Furong Zeng et al.
FRONTIERS IN ONCOLOGY (2020)
Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma
Jie Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells
Paramita Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Isoflavone ME-344 Disrupts Redox Homeostasis and Mitochondrial Function by Targeting Heme Oxygenase 1
Leilei Zhang et al.
CANCER RESEARCH (2019)
The chemical basis of ferroptosis
Marcus Conrad et al.
NATURE CHEMICAL BIOLOGY (2019)
Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis
Mara Gagliardi et al.
CELL DEATH & DISEASE (2019)
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Jose Pedro Friedmann Angeli et al.
NATURE REVIEWS CANCER (2019)
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
Grant M. Fischer et al.
PIGMENT CELL & MELANOMA RESEARCH (2018)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Shilpak Chatterjee et al.
CELL METABOLISM (2018)
S-Glutathionylation of estrogen receptor α affects dendritic cell function
Jie Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Adam J. Wolpaw et al.
TRENDS IN CELL BIOLOGY (2018)
Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
Raeeka Khamari et al.
CELL DEATH & DISEASE (2018)
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Ali Talebi et al.
NATURE COMMUNICATIONS (2018)
Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana
Julie Kovarova et al.
PLOS PATHOGENS (2018)
Rapid complete remission of metastatic melanoma after first- line treatment with nivolumab plus tumor-infiltrating lymphocytes
Lingdi Zhao et al.
IMMUNOTHERAPY (2018)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells
Farhan Basit et al.
CELL DEATH & DISEASE (2017)
Intratumoral gold-doxorubicin is effective in treating melanoma in mice
Xuan Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Laura Schoeckel et al.
CANCER & METABOLISM (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma
Darshil J. Shah et al.
MAYO CLINIC PROCEEDINGS (2014)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Microsomal glutathione transferase 1: mechanism and functional roles
Ralf Morgenstern et al.
DRUG METABOLISM REVIEWS (2011)
Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO
Steven Hutchens et al.
INVESTIGATIONAL NEW DRUGS (2011)
NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance
Danyelle M. Townsend et al.
CANCER RESEARCH (2008)
Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response
K. Lei et al.
ONCOGENE (2008)
PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
JE Saavedra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A glutathione S-transferase π-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
DM Townsend et al.
MOLECULAR PHARMACOLOGY (2006)
分享论文
